In this Tech Talk, Novartis and Dawn Health share the story behind Nelia - a patient-centric digital solution designed to support individuals living with rare genetic diseases (RGD). Johannes Boshkow, Senior Business Development Director at Dawn Health, and Christof Wedemeyer, Director of Patient Experience & CRM at Novartis, will reflect on the insights that shaped the product, the collaborative process that made it possible, and how co-creation enabled them to build a scalable yet personalized digital experience. The conversation explores the unique challenges in rare disease, the power of partnerships across pharma and tech, and what it takes to deliver impactful solutions in an evolving healthcare landscape.